120 related articles for article (PubMed ID: 38123984)
1. Specific gut pathobionts escape antibody coating and are enriched during flares in patients with severe Crohn's disease.
Eriksen C; Danneskiold-Samsøe NB; Moll JM; Myers PN; Bondegaard PW; Vejrum S; Hansen TB; Rosholm LB; Rausch P; Allin KH; Jess T; Kristiansen K; Penders J; Jonkers D; Brix S
Gut; 2024 Feb; 73(3):448-458. PubMed ID: 38123984
[TBL] [Abstract][Full Text] [Related]
2. Patients With Inflammatory Bowel Disease Show IgG Immune Responses Towards Specific Intestinal Bacterial Genera.
Bourgonje AR; Roo-Brand G; Lisotto P; Sadaghian Sadabad M; Reitsema RD; de Goffau MC; Faber KN; Dijkstra G; Harmsen HJM
Front Immunol; 2022; 13():842911. PubMed ID: 35693832
[TBL] [Abstract][Full Text] [Related]
3. Crohn's disease patients have more IgG-binding fecal bacteria than controls.
Harmsen HJ; Pouwels SD; Funke A; Bos NA; Dijkstra G
Clin Vaccine Immunol; 2012 Apr; 19(4):515-21. PubMed ID: 22336288
[TBL] [Abstract][Full Text] [Related]
4. Salivary IgA and IgG Antibody Responses against Periodontitis-Associated Bacteria in Crohn's Disease.
Gürsoy M; Rautava J; Pussinen P; Kristoffersen AK; Enersen M; Loimaranta V; Gürsoy UK
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768711
[TBL] [Abstract][Full Text] [Related]
5. IgG and IgM cooperate in coating of intestinal bacteria in IgA deficiency.
Eriksen C; Moll JM; Myers PN; Pinto ARA; Danneskiold-Samsøe NB; Dehli RI; Rosholm LB; Dalgaard MD; Penders J; Jonkers DM; Pan-Hammarström Q; Hammarström L; Kristiansen K; Brix S
Nat Commun; 2023 Dec; 14(1):8124. PubMed ID: 38065985
[TBL] [Abstract][Full Text] [Related]
6. Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response.
Furrie E; Macfarlane S; Cummings JH; Macfarlane GT
Gut; 2004 Jan; 53(1):91-8. PubMed ID: 14684582
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin subtype-coated bacteria are correlated with the disease activity of inflammatory bowel disease.
Masu Y; Kanazawa Y; Kakuta Y; Shimoyama Y; Onodera M; Naito T; Moroi R; Kuroha M; Kimura T; Shiga H; Kinouchi Y; Masamune A
Sci Rep; 2021 Aug; 11(1):16672. PubMed ID: 34404881
[TBL] [Abstract][Full Text] [Related]
8. Dynamic immunoglobulin responses to gut bacteria during inflammatory bowel disease.
Rengarajan S; Vivio EE; Parkes M; Peterson DA; Roberson EDO; Newberry RD; Ciorba MA; Hsieh CS
Gut Microbes; 2020 May; 11(3):405-420. PubMed ID: 31203722
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of soluble immunoglobulins A and G and their coated bacteria in feces of patients with inflammatory bowel disease.
Lin R; Chen H; Shu W; Sun M; Fang L; Shi Y; Pang Z; Wu W; Liu Z
J Transl Med; 2018 Dec; 16(1):359. PubMed ID: 30558634
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin subclass distribution and dynamics of Shigella-specific antibody responses in serum and stool samples in shigellosis.
Islam D; Wretlind B; Ryd M; Lindberg AA; Christensson B
Infect Immun; 1995 May; 63(5):2054-61. PubMed ID: 7729920
[TBL] [Abstract][Full Text] [Related]
11. Interactions between the Gut Microbiome and Mucosal Immunoglobulins A, M, and G in the Developing Infant Gut.
Janzon A; Goodrich JK; Koren O; ; Waters JL; Ley RE
mSystems; 2019 Nov; 4(6):. PubMed ID: 31771976
[TBL] [Abstract][Full Text] [Related]
12. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.
Macpherson A; Khoo UY; Forgacs I; Philpott-Howard J; Bjarnason I
Gut; 1996 Mar; 38(3):365-75. PubMed ID: 8675088
[TBL] [Abstract][Full Text] [Related]
13. Anti-food and anti-microbial IgG subclass antibodies in inflammatory bowel disease.
Jansen A; Mandić AD; Bennek E; Frehn L; Verdier J; Tebrügge I; Lutz H; Streetz K; Trautwein C; Sellge G
Scand J Gastroenterol; 2016 Dec; 51(12):1453-1461. PubMed ID: 27455092
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin G (IgG), IgG1, and IgG2 determinations from endoscopic biopsy specimens in control, Crohn's disease, and ulcerative colitis subjects.
Rüthlein J; Ibe M; Burghardt W; Mössner J; Auer IO
Gut; 1992 Apr; 33(4):507-12. PubMed ID: 1582596
[TBL] [Abstract][Full Text] [Related]
15. Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children.
De Palma G; Nadal I; Medina M; Donat E; Ribes-Koninckx C; Calabuig M; Sanz Y
BMC Microbiol; 2010 Feb; 10():63. PubMed ID: 20181275
[TBL] [Abstract][Full Text] [Related]
16. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
17. Systemic and mucosal antibodies to Klebsiella in patients with ankylosing spondylitis and Crohn's disease.
O'Mahony S; Anderson N; Nuki G; Ferguson A
Ann Rheum Dis; 1992 Dec; 51(12):1296-300. PubMed ID: 1485810
[TBL] [Abstract][Full Text] [Related]
18. Serum immunoglobulin G subclasses in patients with ulcerative colitis and Crohn's disease of different disease activities.
Philipsen EK; Bondesen S; Andersen J; Larsen S
Scand J Gastroenterol; 1995 Jan; 30(1):50-3. PubMed ID: 7701250
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin A Targets a Unique Subset of the Microbiota in Inflammatory Bowel Disease.
Shapiro JM; de Zoete MR; Palm NW; Laenen Y; Bright R; Mallette M; Bu K; Bielecka AA; Xu F; Hurtado-Lorenzo A; Shah SA; Cho JH; LeLeiko NS; Sands BE; Flavell RA; Clemente JC
Cell Host Microbe; 2021 Jan; 29(1):83-93.e3. PubMed ID: 33385335
[TBL] [Abstract][Full Text] [Related]
20. Differential prevalence of pathobionts and host gene polymorphisms in chronic inflammatory intestinal diseases: Crohn's disease and intestinal tuberculosis.
Khan IA; Nayak B; Markandey M; Bajaj A; Verma M; Kumar S; Singh MK; Kedia S; Ahuja V
PLoS One; 2021; 16(8):e0256098. PubMed ID: 34407136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
